Kidney International study finds promising oral drug for PH2
NewsBytes | April 7, 2026 4:39 PM CST
N-PPG reduced kidney stones in mice
The medication, called N-propargylglycine (N-PPG), blocks an enzyme that triggers excess oxalate production, the main culprit behind PH2.
In mouse studies, those given N-PPG had fewer kidney stones and healthier kidneys than untreated mice.
While more research is needed before it's available for people, this breakthrough could make life a lot easier for those living with PH2.
READ NEXT
-
English Channel: Four Migrants Die Off French Coast During UK Crossing Attempt
-
‘Women Placed Higher Than Men’: Centre Defends Sabarimala Stand In SC
-
Aries, Taurus, Gemini Horoscope Today – 10th April 2026: Career Shifts, Emotional Clarity & Major Decisions
-
IMF to cut global growth forecast due to Mideast war
-
Cancer, Leo, Virgo Horoscope Today – 10th April 2026: Emotional Shifts, Career Focus & Creative Breakthroughs
